ClinicalTrials HQ

Cancer Hospital, Chinese Academy of Medical Sciences

Cancer Hospital, Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China

41 results ยท Page 1 of 2

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Activity of HF50 in Patients With Advanced Solid TumorsAdvanced Solid TumorsRecruitingPhase 12026-09-28NCT07601334
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid TumorsLocally Advanced Solid TumorRecruitingPhase 12026-09-25NCT06349408
A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid TumorsPatients With Advanced Solid TumorsNot yet recruitingPhase 12026-08-26NCT07787520
Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC StudyMeta-Learning; Multimodal; Predictive Models; Triple -Negative Breast CancertripleRecruitingNot stated2026-08-19NCT07773818
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerDisease Attributes, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasmRecruitingNot stated2026-08-18NCT06993506
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical CancerCancer of the Uterine Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorderRecruitingNot applicable2026-08-05NCT07684508
Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder CancerFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorderActive, not recruitingNot stated2026-07-30NCT07735858
A Phase II Study of Radiation Therapy to Treat Refractory Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderNot yet recruitingNot applicable2026-06-29NCT07672743
Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderNot yet recruitingNot applicable2026-06-18NCT07657442
Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.Advanced Triple-negative Breast CancerRecruitingPhase 22026-06-10NCT06771609
A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast CancerAdvanced Breast CancerRecruitingNot stated2026-06-09NCT06776861
A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced or Metastatic Squamous Non-Small Cell Lung CancerRecruitingPhase 2 / Phase 32026-06-01NCT07459751
A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast CancerUnresectable Locally Metastatic Breast Cancer; Unresectable Locally Recurrent Breast CancerRecruitingPhase 22026-05-11NCT07497386
This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 12026-05-01NCT07249879
A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract CancerBiliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract cancer, biliary tract disorder, neoplasmRecruitingPhase 22026-03-31NCT07450976
A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 2 / Phase 32026-03-20NCT07294508
Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive AscitesAscites, Pathologic Processes, Pathological Conditions, Signs and SymptomsRecruitingPhase 1 / Phase 22026-03-17NCT07435701
The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral CrisisNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 22026-03-16NCT07203729
Response-Based Local Therapy for Regionally Advanced Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 22026-02-11NCT07376538
Toripalimab for High-risk Locally Advanced Cervical CancerCancer of the Uterine Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorderActive, not recruitingPhase 22026-01-02NCT06416696
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, benign prostatic hyperplasia, disease, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderNot yet recruitingNot stated2025-11-20NCT07238959
Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLCNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmNot yet recruitingPhase 22025-05-31NCT06998719
The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical StudyHER2 positive breast carcinomaRecruitingPhase 2 / Phase 32025-05-06NCT06958627
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderNot yet recruitingPhase 32025-04-13NCT06922903
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical TreatmentProstate Cancer RecurrentNot yet recruitingPhase 32025-04-11NCT06922929